Metropolitan Life Insurance Company (MetLife)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-10,600
| Closed | -$509K | – | 2644 |
|
|
2020
Q1 | $509K | Hold |
10,600
| – | – | 0.01% | 1037 |
|
|
2019
Q4 | $497K | Hold |
10,600
| – | – | 0.01% | 1327 |
|
|
2019
Q3 | $251K | Buy |
10,600
+4,037
| +62% | +$95.5K | ﹤0.01% | 1725 |
|
|
2019
Q2 | $197K | Buy |
6,563
+1,059
| +19% | +$31.8K | ﹤0.01% | 1897 |
|
|
2019
Q1 | $123K | Hold |
5,504
| – | – | ﹤0.01% | 2198 |
|
|
2018
Q4 | $100K | Buy |
+5,504
| New | +$100K | ﹤0.01% | 2267 |
|
|
2017
Q3 | – | Sell |
-8,878
| Closed | -$166K | – | 2563 |
|
|
2017
Q2 | $166K | Buy |
+8,878
| New | +$166K | ﹤0.01% | 2447 |
|